Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q40331927)
Watch
English
The podophyllotoxin derivatives VP16-213 and VM26.
scientific article published on January 1982
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
review article
1 reference
stated in
Europe PubMed Central
title
The podophyllotoxin derivatives VP16-213 and VM26
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
author name string
B F Issell
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
publication date
1 January 1982
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
published in
Cancer Chemotherapy and Pharmacology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
volume
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
issue
2-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
page(s)
73-80
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
cites work
PTG, a new antineoplastic epipodophyllotoxin
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Evaluation of VP-16-213 in malignant lymphoma and melanoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A phase II study of oral VP-16-213 in non-seminomatous testicular cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Acute monoblastic leukemia: diagnosis and treatment of ten cases
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
PHASE I clinical trial of an oral solution of VP-16-213
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cis-dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non-small cell lung cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Etoposide (VP-16-213)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Use of VM-26 as a single agent in the treatment of renal carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP16-213 as a single agent in advanced testicular tumors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
EPEG, a new antineoplastic epipodophyllotoxin
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP 16-213 in acute myelogenous leukaemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VM26 (NSC-122819): A clinical study in advanced cancer of the lung and ovary
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Clinical study of the new podophyllotoxin derivative, 4'-demethylepipodophyllotoxin 9-(4,6-o-ethylidene- beta-D-glucopyranoside) (NSC-141540; VP-16-213), in solid tumors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Epipodophyllotoxin (VP 16-213) in the treatmetn of diffuse histiocytic lymphoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase I trial of a new form of an oral administration of VP-16-213
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Chemotherapy of small cell carcinoma of the lung with V. P. 16–213
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment of small cell bronchogenic carcinoma with VM-26
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP-16–213 salvage therapy for refractory germinal neoplasms
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II clinical trial of VP-16-213 in ovarian cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II study of VM-26 in adult malignancies
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Activity of the epipodophyllotoxin VP-16 in the treatment of combination chemotherapy-resistant non-Hodgkin lymphoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VM-26 as a second drug in the treatment of brain gliomas
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Pulmonary hyaline membrane disease occurring in the course of VM-26 therapy
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase I clinical trial of weekly administration of 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II trial of VM-26 in patients with metastatic malignant melanoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/7044593
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1007/BF00254525
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
Dimensions Publication ID
1020288415
0 references
PubMed publication ID
7044593
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7044593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7044593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
